Dr. Ken McClain, co-director of Texas Children’s Cancer and Hematology Centers Histiocytosis Program, recently received the 2019 George R. Buchanan Lectureship Award from the American Society of Pediatric Hematology/Oncology (ASPHO). He is the fourth recipient of this national award honoring a significant contributor in the field.
Specifically, the award recognizes McClain as an international expert in pediatric hematology/oncology, an accomplished educator, committed mentor and effective speaker whose significant research, education and clinical expertise is of the caliber of achievements made by Buchanan, who made scientific contributions in many areas of pediatric hematology and oncology, and has been recognized as an outstanding teacher and mentor.
As part of receiving the Buchanan award, McClain was invited to present a 35 minute state-of-the-art lecture describing his research following the award presentation earlier this month. His talk was on the history of Langerhans Cell Histiocytosis.